American Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

American Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-21	Closed	-$1K	–	19
2015 Q3	$1K	Buy	+21	New	+$1.33K	﹤0.01%	101
2014 Q4	–	Sell	-21	Closed	-$1K	–	18
2014 Q3	$1K	Buy	+21	New	+$1.05K	﹤0.01%	110

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

American Asset Management's BMY Position: Q4 2015 in Review

American Asset Management sold out of Bristol-Myers Squibb (BMY) in Q4 2015, closing a stake of 21 shares — an estimated $1K sold.

American Asset Management first reported a position in BMY in Q3 2014 and held it in 2 quarters. The position peaked at $1K in Q3 2015. 1,534 funds tracked by Wall St. Rank hold BMY as of Q4 2015.

American Asset Management reported no remaining Bristol-Myers Squibb position as of Q4 2015 after selling out during the quarter.
American Asset Management sold 21 Bristol-Myers Squibb shares in Q4 2015, an estimated $1K.
American Asset Management first reported a position in Bristol-Myers Squibb in Q3 2014 and held it in 2 quarters.
American Asset Management's Bristol-Myers Squibb position peaked at $1K in Q3 2015.
1,534 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2015.

Based on American Asset Management's 13F filing for Q4 2015, filed 19 Jan 2016.